OASAS: Clarification on SARS-CoV-2 (COVID-19)
June 26, 2023
See below clarification from OASAS Chief Medical Officer Dr. Kelly Ramsey re: the Webinar OASAS hosted last Friday re: OASAS end of PHE guidance. We sent you the recording and documents from the Webinar on Friday evening at 7:23 pm.
———- Forwarded message ———
From: OASAS.sm.Communications <OASAS.sm.Communications@oasas.ny.gov>
Date: Mon, Jun 26, 2023 at 2:04 PM
Subject: Clarification on SARS-CoV-2 (COVID-19) POC Ag Testing Requirements
To: ALL-PROVIDERS-L@LISTSERV.OASAS.NY.GOV <ALL-PROVIDERS-L@listserv.oasas.ny.gov>
Dear Providers,
I mentioned on the 6/23/23 webinar with OASAS providers on the changes with respect to the COVID-19 guidance documents that we were waiting to hear back from the NYS DOH regarding COVID-19 POC Ag testing recommendations for asymptomatic, non-exposed persons. I confirmed with the DOH today that the FDA recommendations for testing do not distinguish between exposed or non-exposed persons. The recommendation remains 3 tests, separated by 48 hours (days 1, 3, 5) for asymptomatic persons and 2 tests, separated by 48 hours (days 1 and 3) for symptomatic persons.
See FDA recommendations here: https://www.fda.gov/medical-devices/covid-19-emergency-use-authorizations-medical-devices/in-vitro-diagnostics-euas-antigen-diagnostic-tests-sars-cov-2#SerialTesting
If/when the FDA changes their recommendations, we will inform the OASAS providers.
Thank you.
Office of the CMO